Alba Masip-Jimenez
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Reply: Rethinking sustained recompensation in MASLD cirrhosis: The value of pharmacological maintenance.
Journal: Hepatology communications
Published: April 22, 2026
The rate and predictors of recompensation in patients with decompensated cirrhosis due to metabolic dysfunction-associated liver disease (MASLD).
Journal: Hepatology communications
Published: December 11, 2025
Hepatic venous pressure gradient, non-invasive tests, and prognosis across the subtypes of advanced steatotic liver disease.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: December 11, 2025
Hepatic Venous Pressure Gradient, Noninvasive Tests, and Prognosis Across the Subtypes of Advanced Steatotic Liver Disease.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: December 11, 2025
Prevalence of liver fibrosis in the general population (the LiverScreen project): a multinational European cohort study.
Journal: Lancet (London, England)
Published: September 17, 2025
Assessment and management of portal hypertension in patients with MASLD: advances and caveats.
Journal: Expert review of gastroenterology & hepatology
Published: July 08, 2025
Incidence and implications of abstinence-induced recompensation in alcohol-related cirrhosis.
Journal: Journal of hepatology
Published: July 08, 2025
Incidence and implications of abstinence-induced recompensation in alcohol-related cirrhosis.
Journal: Journal of hepatology
Published: July 08, 2025
Opportunistic case-finding of liver fibrosis in metabolic dysfunction-associated steatotic liver disease (MASLD) by leveraging integrated care pathways of type 2 diabetes.
Journal: Hepatobiliary surgery and nutrition
Published: May 18, 2025
Metabolic dysfunction-associated steatotic liver disease in prison populations: a review of its impact and current and future challenges.
Journal: Revista espanola de sanidad penitenciaria
Published: May 05, 2025
Autoantibodies are associated with worse outcomes in MASLD.
Journal: JHEP reports : innovation in hepatology
Published: January 29, 2025
Predicting Hepatic Decompensation in Patients With Metabolic Dysfunction Associated Steatotic Liver Disease-Related Cirrhosis: The ABID-LSM Model.
Journal: Alimentary pharmacology & therapeutics
Published: January 20, 2025
Last Updated: 09/26/2026